You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (52)

Journals (0)

1-10 of 52 results for low-dose rituximab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab

Retricted access

Case report

First published 2020-12

Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab

Wanlu Ma, Wei Bai, Xueyan Wu [...]

Lupus

Select article: A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus

Open access

Research article

First published 2021

A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus

Shuo Zhang, Nan Jiang, Li Wang [...]

Sage Open Chronic Disease

Select article: Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis

Open access

Research article

First published 2019

Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis

Kyomin Choi, Yoon-Ho Hong, So-Hyun Ahn [...]

Therapeutic Advances in Neurological Disorders

Select article: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy

Retricted access

Research article

First published 2021-05

Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy

Guia Vannucchi, Irene Campi, Danila Covelli [...]

Thyroid®

Select article: Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum

Retricted access

Research article

First published 2013-10

Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum

M Ringelstein, J Harmel, F Distelmaier [...]

Multiple Sclerosis Journal

Select article: De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy

Retricted access

Research article

First published 2026-4

De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy

Annette M Langer-Gould, Jessica B Smith, Allen Scott Nielsen [...]

Multiple Sclerosis Journal

Select article: Low-dose rituximab should be used for treating MS in resource-limited settings: No

Open access

Research article

First published 2022-6

Low-dose rituximab should be used for treating MS in resource-limited settings: No

Farrah J Mateen

Multiple Sclerosis Journal

Select article: Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary

Retricted access

Research article

First published 2022-6

Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary

Claudia Cárcamo, Ethel Ciampi

Multiple Sclerosis Journal

Select article: Low-dose rituximab should be used for treating MS in resource-limited settings: Yes

Open access

Research article

First published 2022-6

Low-dose rituximab should be used for treating MS in resource-limited settings: Yes

Fredrik Piehl, Thomas Mathew

Multiple Sclerosis Journal

Select article: A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis

Open access

Research article

First published 2020-10

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis

Björn Evertsson, Tammy Hoyt, Angel Christensen [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

1
2
3
•••
6
10 / page

Article type

Publication date

Subjects

Access